Questions related to Psychedelics
For my masters in psychology I'm investigating some potential crossover effects between 12-step facilitation and the use of psychedelic drugs for the treatment of substance abuse. I'm looking to recruit those who currently attend 12-step meetings, and those who attend but have also used a psychedelic to aid in their recovery. I intend to compare the two groups on certain measures related to their recovery journey.
I have asked permission on various threads on Reddit specifically related to 12-step facilitation, alcohol abuse and drug abuse but have been denied access on all occasions. I have also tried to target In the Rooms, a social media site dedicated to those in recovery, but was also turned away. Understandably, these online spaces want to create a safe and welcoming place for people to share their experiences, not one filled with survey links. Also, as 12-step attendance promotes total abstinence from all drugs, I'm sure the subject nature of my study is probably very off-putting to a lot of the gatekeepers of these communities. I created a facebook page and boosted a post for a week but with little to no pickup as it was impossible to target the 12-step population given the filters at my disposal, besides choosing countries with the highest number of 12-step fellowships.
I have had more success recruiting psychedelic users who also attend 12-step through sub-reddits related to psychedelics, as well as with some assistance from the a group dedicated to the combination of the two called Psychedelics in Recovery.
However, if anyone has any experience recruiting from the traditional 12-step population and is willing to share some useful advice I would be extremely grateful.
Please note that I can't afford to pay anyone for their participation.
I have been looking for good measurement tools to assess people's reasons/motivations for using psychedelics but have not had any luck finding validated or reliable measures... does anyone have suggestions or leads?
I am a student at the University of Bolton studying Psychology, Psychotherapy and Counselling, I am entering my third year in September. I will be doing my dissertation on psychedelics usage for mental health conditions.
Are there any qualitative questionnaires that people have come across for this use?
I am currently in the last steps of planning my PhD thesis, which focuses on some aspects of psychedelics. The first part of the project is a survey composed of multiple demographic questions, as well as information and scales about the participants' psychedelic experience.
Since the survey will be available without incentives (given the illegal nature of the topic), and could be a bit lengthy compared to other questionnaires, I am expecting some incomplete answers (most likely due to participant fatigue). Nevertheless, I have done pretty much everything to minimize this (survey as short as possible, estimated completion time, progress line, concise questions, limited open-ended questions etc.)
In my ethics application, I have written that given the illegal and stigmatized nature of the topic, incomplete answers will be treated as a voluntary withdrawal from the study, and the incomplete responses will be deleted as to maximize participant autonomy and privacy. Is this a good way to approach this? If not, what would you recommend?
Reality is likely a frame-stack, light particles hit the eye at different times but all these individual frames impact the receptors after one another and are stacked together.
High frequency variable focus cameras can pick up a 3D image with a single lens.
This means it is not so strange to still see in 3D with one eye closed.
Frames on salvinorin A can shake and bend vigorously.
This week's blog post is about a surprising recent trend in mental health treatment: psychedelic drugs are making a comeback. Far from the trippy image of the 1960s, these medications are now the subject of serious scientific study and have been featured in the pages of Good Housekeeping magazine. Yet they still carry risks. Here's a post on the current status of these treatments: https://sites.google.com/view/two-minds/blog
I am curious about whether or not there are potential benefits to psilocybin when relating to substance abuse and addiction treatment? Due to certain factors there has been a limited amount of research but I would love to learn more about this topic.
Altered states of consciousness (ASC) induced by meditation, psychedelic drugs, or impending death are quite a fascinating but challenging field of investigation. By exploring the mechanisms behind essential phenomena in ASC from a unique perspective, we find out that ASC are a story about perception in nature: The interaction between two sources of stimulation to perception, the shutting down of perception, the filtering mechanism of perception and the delusions of perception.
At the meantime, we discover the correlation between Buddhism and ASC: the essence of Buddhist Vipassana is enhanced awareness in ASC.
Thereupon we introduce time dimension and reveal the science behind Buddhism.
Altered states of consciousness (ASC) induced by meditation, psychedelic drugs, or impending death are quite a fascinating and important field of investigation. This paper argues that ASC essentially have nothing to do with consciousness, but a story about perception. Furthermore, by introducing time dimension, we reveal the science behind Buddhism from a psychological perspective.
Our study starts from summarizing four essential phenomena (hallucinations, paranormal phenomena, mystical experiences and enhanced awareness) in ASC on the basis of empirical materials of Aldous Huxley, Timothy Leary and others.
Then we propose an original model for hallucinations as a breakthrough: When false internal stimulations and external objective stimulations affect perception together, the changes in their relative strength will result in the consistence, breakdown and re-consistence of the five senses, leading to three basic states of hallucinations (one can distinguish reality from fantasy, one cannot distinguish reality from fantasy, and reality and fantasy are totally reversed).
As an implication of this model, the third state of hallucinations suggests a novel hypothesis to interpret extrasensory perception (ESP): the essence of ESP is that false internal stimulations are mistaken as external objective stimulations which enter through sensory organs, while real external objective stimulations are mistaken as perceptions which do not result from sensory organs when one is in deep hallucinations. Moreover, in the second state of hallucinations, the inconsistence of the five senses can also explain various marvelous psychedelic phenomena in ASC in combination with the amplifying function of enhanced awareness discussed later and the mechanism of out-of-body experiences. Thus, we arrive at a conclusion that paranormal phenomena are simply illusions that happen along with deep hallucinations.
Mystical experiences occur in Samatha. Based on the experiential description, it can be inferred that the essence of Samatha is perception shutting down to activate a new mode of apperceiving, one totally different from the usual five sense mode of perception. Hallucinations also disappear because perception shuts down.
Enhanced awareness is highly significant in ASC and could be explained by a perception-filtering model in light of Henri Bergson’s innovative idea: In ordinary conditions, perception has a natural threshold for its sensitivity for the purpose of biological survival; but in ASC, awareness becomes more sensitive because the perception-filtering function gets weakened to allow the influx of more details, resulting in various unusual capabilities, one of which is Buddhist Vipassana.
Finally, we develop a universal framework comprising two dimensions (three mechanisms and three stages) to study ASC. By figuring out the complex relationship among them, we reveal the mystery between Buddhist tranquility and insight: Enhanced awareness after Samatha is the path to attain enlightenment.
Recent research in cognitive neuroscience shows that the dopaminergic neurotransmission is correlated to creativity (both to the genesis of creative ideas and their elaboration). However, a direct stimulation of the dopaminergic neurotransmission is risky due to side-effects and an eventual blockade of creativity (and cognitive function in general).
Stimulation with psychedelics could provide some increase in creativity, but in larger doses it is also risky (due to e. .g. psychosis, loss of touch with reality, blockage of thought). The exception of the psychedelic 2-CB could provide an alternative (no 5-HT1A agonism). In this vein, it seems that the agonism at 5-HT2A receptors by 2-CB could enhance creativity safely (in moderate doses).
Therefore, can one assert that coffee (not only caffeine) can act in a similar way to 2-CB and in fact enhance creativity (by potentiating glutamatergic neurotransmission)?
Both coffee and 2-CB share the following characteristics required for creativity: an increase of associations and an increase of visual/conceptual acuity (a prerequisite for the gathering of the building blocks/details needed for the associations of ideas/images).
I'm looking for any research done on psychedelic assisted group psychotherapy. The research papers out there seem to be a challenge to access.
Is it currently possible in the UK to carry out research studies on the interaction between animals and psychedelics? If yes, which drugs are allowed? Around the end of the year I'll start an MRes in Animal Behaviour, which belongs to a Neuroscience department; my previous undergrad dissertation was a summary of 8,000 words about the history of altered states of consciousness through different points of view (psychological, ethnic and anthropological, chemical etc.) so it would be amazing to continue my path through this line and maybe find some tangible feedbacks.
The claustrum has remained one of the most enigmatic structures in the brain for several centuries. It is a thin, irregular sheet of gray matter, with one located on each side of the brain. It lies under the inner surface of the neocortex, below the general region of the insula, and above the outer surface of the putamen, with fiber tracts on each side: the extreme and external capsules. It has a small size, a very peculiar location and shape, and it is therefore probably very difficult to study it´s connections. It has the highest density of 5-HT2A receptors in the brain, and therefore it might be previously unrecognized, but also very important target of antipsychotics and psychedelics.
What is the exact function and role of the claustrum in the brain?
I'm trying to define impact of substituted cathinones on depression. To my surprise, majority of my patients who use substituted cathinones are also using many other substances, but I have no detailed data about patients' other drugs usage except for the names of substances. I have detailed data on how often they take the cathinones though, therefore I want to divide the substances into 2 or 3 groups based on these substances' impact on depression for analytical reasons. I don't want to miss any approach during analyzing.
The full list I asked them about contains alcohol, marihuana, amphetamine, meth, MDMA, cocaine, ketamine, LSD/DMT/psylocybine and 2C phenethylamines and "others".
I thought about dividing them into stimulants, depressants and psychedelics, which seems the most reasonable fragmentation to do. Any thoughts?
I've seen several studies that used the HRS with different drugs but can't seem to find the items themselves.
I could find only the version in Portuguese.
Anyone knows where I might find them in English (or hebrew)?
I already know about their use to treat anxiety, depression addiction, i'm looking for anything else about their use to treat anorexia nervosa or bulimia. Thanks
I am curious about the phenomenology of psychedelics states as experienced by individuals with endogenous psychosis. I would be interested in knowing what influence the normalization of psychotic states (as in chronic schizophrenia) would have on the interpretation and integration of psychedelic experiences.
“participants rated the vividness of colour experiences and selected speciﬁc colours in response to a set of graphemes (letters/sounds like ‘S’, ‘U’, ‘OO’) and sounds in L SD and placebo conditions. Participants also independently completed measures of absorption and visual imagery” (Terhune et al. 2016). Is that a good measure for “experience of drug-induced synaesthesia-like experiences”. LSD volunteers are not reliable because they’re in no uncertain terms behaving unpredictably. The evidence suggests they are in a disorganised, creative, and free roaming state of consciousness (Kaelenso et al. 2014) to use any type of self-assessment would be fraught with subjectivity and miscommunication through their own sensitivity to emotional states and others, this is related to atypical experiences under the effect of psychedelic drugs. I don’t think it is feasible to test highly sensitive individuals, in lucid dream-like states of mind under controlled experimental conditions without controlling for said conditions, we would ideally need a condition control group as well as a placebo control condition group, although in my opinion a placebo control isn’t necessary because we are aware the drugs are having a distinct effect and do not need confirmation that these effects are not being caused by placebo effects. What we need to account for is the set and setting, the old idiom of many experienced users of psychedelic drugs, including but not limited to culturally relevant rituals, such as you may refer to in shamanic practices. Although these rituals are highly relevant in western societies too, referring to Free-Masonry practices where ritual is highly relevant in inducing specific states of consciousness.
hi, im looking for any document about psychoactive plants or roots here in america before 1521, if u have some text where i could find information i'll be grateful
I'm looking for Chilean researchers interested in psychedelic research for sharing ideas and research projects.
I am currently elaborating a lineage explanation of a modern human behavioural trait: psychedelic pharmacophagy (or the beneficial ingestion of "mind-manifesting" substances).
The purpose is to show how small changes in biological and cultural mechanisms can take us from ancestral ape's rudimentary capacities for tolerating and sometimes exploiting secondary metabolites to modern humans' capacity to instrumentalize psychedelics in order to enhance cognition and social bonding. In other words, I want to explain the origins of such an evolutionary novelty by making plausible certain trajectory of change through phenotypic space.
For this purpose, I would like to examine articles that have tried to do something similar, i.e. elaborate a lineage explanation of a behavioral trait (and not a physiological or morphological one like, say, the eyes) in order to have some examples to use as paradigmatic input.
Any advice and suggestions will be greatly appreciated.
What kind of therapeutic processes are responsble for psychedelic therapy's positive outcomes? Emotional abreaction? Increased self-awareness? Maximized access to subconscious/repressed material? Transpersonal experiences?
I'm gathering research data on psychedelic experience for my Masters dissertation. I'd like to link the ayahuasca experience with Eugene Gendlin's experiential theory and the embodiment paradigm. Any suggestions, comments, etc.?